1. Asn-Gly-Arg-modified polydopamine-coated nanoparticles for dual-targeting therapy of brain glioma in rats.
- Author
-
Hu J, Zhang X, Wen Z, Tan Y, Huang N, Cheng S, Zheng H, and Cheng Y
- Subjects
- Animals, Blood-Brain Barrier metabolism, Brain Neoplasms drug therapy, CD13 Antigens metabolism, Cell Survival, Disease Models, Animal, Drug Carriers, Drug Delivery Systems, Drug Liberation, Glioma drug therapy, Male, Microscopy, Confocal, Molecular Imaging, Molecular Targeted Therapy, Permeability, Protein Binding, Rats, Tissue Distribution, Xenograft Model Antitumor Assays, Antineoplastic Agents administration & dosage, Brain Neoplasms metabolism, Brain Neoplasms pathology, Glioma metabolism, Glioma pathology, Indoles chemistry, Nanoparticles chemistry, Nanoparticles ultrastructure, Oligopeptides administration & dosage, Polymers chemistry
- Abstract
The blood-brain barrier (BBB) is the major clinical obstacle in the chemotherapeutic management of brain glioma. Here we synthesized a pH-sensitive dual-targeting doxorubicin (DOX) carrier to compromise tumor endothelial cells, enhance BBB transportation, and improve drug accumulation in glioma cells. The drug delivery system was constructed with polydopamine (PDA)-coated mesoporous silica nanoparticles (NPs, MSNs) and the PDA coating was functionalized with Asn-Gly-Arg (NGR), a ligand with specific affinity for cluster of differentiation 13 (CD13). MSN-DOX-PDA-NGR showed a higher intracellular accumulation in primary brain capillary endothelial cells (BCECs) and C6 cells and greater BBB permeability than the non-targeting NPs (MSN-DOX-PDA) did in vitro. Ex vivo and in vivo tests showed that MSN-DOX-PDA-NGR had a higher accumulation in intracranial tumorous tissue than the undecorated NPs did. Furthermore, the antiangiogenesis and antitumor efficacy of MSN-DOX-PDA-NGR were stronger than that of MSN-DOX-PDA. Therefore, these results indicate that the dual-targeting vehicles are potentially useful in brain glioma therapy.
- Published
- 2016
- Full Text
- View/download PDF